Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Yamashita Health Care Holdings's revenue for the
three
months ended in May. 2026 was 円17,261 Mil.
Its revenue for the trailing twelve months (TTM) ended in May. 2026 was 円64,149 Mil.
Yamashita Health Care Holdings's Revenue per Share for the
three
months ended in May. 2026 was 円6,885.12.
Its Revenue per Share for the trailing twelve months (TTM) ended in May. 2026 was 円25,524.21.
Warning Sign:
Yamashita Health Care Holdings Inc revenue growth has slowed down over the past 12 months.
During the past 9 years, Yamashita Health Care Holdings's highest 3-Year average Revenue per Share Growth Rate was 6.50% per year. The lowest was -4.20% per year. And the median was 0.25% per year.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Yamashita Health Care Holdings Revenue Related Terms
Yamashita Health Care Holdings Revenue Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Yamashita Health Care Holdings's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yamashita Health Care Holdings Revenue vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Yamashita Health Care Holdings's Revenue distribution charts can be found below:
* The bar in red indicates where Yamashita Health Care Holdings's Revenue falls into.
Yamashita Health Care Holdings Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in May. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円64,149 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yamashita Health Care Holdings (TSE:9265) has a Revenue of 円64,149 Mil as of May. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Yamashita Health Care Holdings and its competitors.
Is Yamashita Health Care Holdings' Revenue too high?
Yamashita Health Care Holdings' current Revenue is 円64,149 Mil. Overall, Yamashita Health Care Holdings has a GF Score™ of 69/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Yamashita Health Care Holdings' Revenue compare to MCK and COR?
Yamashita Health Care Holdings' Revenue of 円64,149 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Medical Distribution company?
A good Revenue depends on the Medical Distribution industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Yamashita Health Care Holdings and its competitors. Yamashita Health Care Holdings's current Revenue is 円64,149 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yamashita Health Care Holdings stock overvalued right now?
Based on GuruFocus' analysis, Yamashita Health Care Holdings (TSE:9265) is currently considered Modestly Overvalued. The stock's GF Value™ is 円2,964.10, compared to a current price of 円3,660.00 — trading 23.5% above its estimated fair value. The current Revenue is 円64,149 Mil. Yamashita Health Care Holdings' overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Yamashita Health Care Holdings (TSE:9265), the current Revenue is 円64,149 Mil as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Yamashita Health Care Holdings (TSE:9265) Overvalued in 2026?
Based on GuruFocus' analysis, Yamashita Health Care Holdings stock appears to be overvalued.
The current stock price of 円3,660.00 is trading 23.5% above its estimated GF Value™ of 円2,964.10.
GuruFocus considers Yamashita Health Care Holdings to be Modestly Overvalued.
Key valuation signals for TSE:9265:
Revenue: 円64,149 Mil
GF Value™: 円2,964.10 vs. price of 円3,660.00 (23.5% above fair value)
No single metric tells the full story. See the TSE:9265 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Yamashita Health Care Holdings Inc is a Japan-based medical equipment wholesale company that sells medical equipment for medical institutions within the Kyushu area. The company is also engaged in the manufacture, sale, leasing, and rental of optical instruments, physicochemical instruments, analytical instruments, measuring instruments, health equipment, exercise equipment, nursing care equipment, animal medical equipment, and veterinary drugs.
69GF Score
Get the complete analysis for TSE:9265
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9265 has been successfully added to your 
